Boston Harbor Angels Blog
The following post is from Antonette Ho, Group Operations Manager at Boston Harbor Angels.
Corbus Pharmaceuticals Wins Exit of the Year Award
Corbus Pharmaceuticals is a clinical stage drug development company targeting rare, chronic, and serious inflammatory and fibrotic diseases with clear unmet needs. One of the great successes in the Boston Harbor Angels portfolio, Corbus was awarded Exit of the Year at the annual end-of-year general meeting in December 2017. Yuval Cohen, CEO of Corbus Pharmaceuticals and Mark Tepper, President […]